This website is for UK Healthcare Professionals only


August: Episode 2     Watch time: 25 min

Psoriasis post-COVID-19: an era of virtual clinics?

Episode two focuses on psoriasis management and treatment considerations in light of COVID-19, sharing experiences of overcoming challenges in individual clinics, and top tips for optimising clinic set-up and psoriasis management now and into the future.2-4

Podcast Series Host

Dr Laura Savage

University of Leeds and Leeds

Teaching Hospitals NHS Trust

Podcast Guest Speakers

Dr Tony Bewley

Barts Health NHS Trust,

The Royal London Hospital and Whipps Cross University Hospitals NHS Trust, London

Lucy Moorhead

St John’s Institute of Dermatology,

Guys Hospital, London


JULY: Episode 1

Clinical trial spotlight - risankizumab and secukinumab head-to-head in plaque psoriasis

AUGUST: Episode 2

Psoriasis in the time of COVID-19: an era of virtual clinics?             

SEPTEMBER: Episode 3

Psoriasis in practice: BAD guideline updates                               

OCTOBER: Episode 4

BAD 2020: virtual congress highlights

NOVEMBER: Episode 5

Are all IL-23s the same?                    

DECEMBER: Episode 6

EADV 2020: congress highlights       


  1. SKYRIZI (risankizumab) Summary of Product Characteristics.
  2. NICE rapid guideline ng169: (Accessed August 2020).
  3. PsoProtect. (Accessed August 2020).
  4. BAD risk stratification grid: (Accessed August 2020).

UK-RISN-210513 Date of Preparation: October 2021